LSD acts as a potent agonist at serotonin 5-HT2A receptors, with potential modulatory effects on neuronal connectivity and neurotransmitter release in brain regions associated with pain perception and neurogenic inflammation. In cluster headache treatment, it appears to interrupt the pathological pain cycle through central neural mechanism alterations, potentially reducing headache frequency and intensity by disrupting aberrant neurological signaling patterns.